Skip to main content
. 2014 May 21;35(36):2460–2467. doi: 10.1093/eurheartj/ehu214

Figure 3.

Figure 3

Unadjusted outcomes of bivalirudin vs. heparins + bailout GPI. ARC, Academic Research Consortium; GPI, glycoprotein IIb/IIIa inhibitor; IDR, ischaemia-driven revascularization; MACE, major adverse cardiac events; MI, myocardial infarction; NACE, net adverse clinical events.